Syed L. Ali

Mardan, KP, Pakistan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Harnessing the gut microbiome to combat tuberculosis: a technological and clinical review.

Harnessing the gut microbiome to combat tuberculosis: a technological and clinical review.

Journal: Frontiers in cellular and infection microbiology

Published: April 04, 2026

Antigenic Multi-Epitope Vaccine Against Ross River Virus Using Capsid and Envelope Proteins via Immunoinformatics and Reverse Vaccinology Approaches.

Antigenic Multi-Epitope Vaccine Against Ross River Virus Using Capsid and Envelope Proteins via Immunoinformatics and Reverse Vaccinology Approaches.

Journal: Microbiology and immunology

Published: February 25, 2026

A conserved capsid-based multi-epitope vaccine targeting dengue virus serotypes (DENV1-4): an integrated computational and in vivo study.

A conserved capsid-based multi-epitope vaccine targeting dengue virus serotypes (DENV1-4): an integrated computational and in vivo study.

Journal: BMC immunology

Published: January 02, 2026

Immunoinformatic Design and Evaluation of a Multi-Epitope mRNA Vaccine RP14914P Targeting Latent Tuberculosis Infection.

Immunoinformatic Design and Evaluation of a Multi-Epitope mRNA Vaccine RP14914P Targeting Latent Tuberculosis Infection.

Journal: Pathogens (Basel, Switzerland)

Published: December 11, 2025

Integrated Computational and In Vivo Assessment of a Novel Multi-Epitope Vaccine Against Dengue Virus Serotype 4 Capsid Protein.

Integrated Computational and In Vivo Assessment of a Novel Multi-Epitope Vaccine Against Dengue Virus Serotype 4 Capsid Protein.

Journal: Microbiology and immunology

Published: December 06, 2025

EP9158H: An Immunoinformatics-Designed mRNA Vaccine Encoding Multi-Epitope Antigens and Dual TLR Agonists for Tuberculosis Prevention.

EP9158H: An Immunoinformatics-Designed mRNA Vaccine Encoding Multi-Epitope Antigens and Dual TLR Agonists for Tuberculosis Prevention.

Journal: Bioengineering (Basel, Switzerland)

Published: September 29, 2025

CP91110P: A Computationally Designed Multi-Epitope Vaccine Candidate for Tuberculosis via TLR-2/4 Synergistic Immunomodulation.

CP91110P: A Computationally Designed Multi-Epitope Vaccine Candidate for Tuberculosis via TLR-2/4 Synergistic Immunomodulation.

Journal: Biology

Published: July 15, 2025

Design of chimera vaccine against cutavirus using vaccinomics and immunoinformatics approaches.

Design of chimera vaccine against cutavirus using vaccinomics and immunoinformatics approaches.

Journal: In silico pharmacology

Published: May 17, 2025

AI-Integrated 3D imaging and modelling for hip morphology assessment in athletes.

AI-Integrated 3D imaging and modelling for hip morphology assessment in athletes.

Journal: Computer methods in biomechanics and biomedical engineering

Published: May 12, 2025

Gene Expression Profiling Identifies CAV1, CD44, and TFRC as Potential Diagnostic Markers and Therapeutic Targets for Multiple Myeloma.

Gene Expression Profiling Identifies CAV1, CD44, and TFRC as Potential Diagnostic Markers and Therapeutic Targets for Multiple Myeloma.

Journal: Cell biochemistry and biophysics

Published: March 25, 2025

Terpenoids modulation of the IFI16-AIM2 interaction for enhanced immune response in lung squamous cell carcinoma and AIM2-dysregulated diseases.

Terpenoids modulation of the IFI16-AIM2 interaction for enhanced immune response in lung squamous cell carcinoma and AIM2-dysregulated diseases.

Journal: In silico pharmacology

Published: February 26, 2025

Leveraging computer-aided design and artificial intelligence to develop a next-generation multi-epitope tuberculosis vaccine candidate.

Leveraging computer-aided design and artificial intelligence to develop a next-generation multi-epitope tuberculosis vaccine candidate.

Journal: Infectious medicine

Published: July 26, 2024

Showing 1-12 of 16

Last Updated: 09/26/2026